Watching Cumberland Pharmaceuticals Inc.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planCumberland Pharmaceuticals Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Cumberland Pharmaceuticals completed a strategic acquisition with Apotex Health Corp on July 13, 2026, receiving $100 million in cash and declaring a special dividend of $1.50 per share, signaling a major business restructuring and shareholder value return.
Key Takeaways
Cumberland sold its U.S.-branded businesses to Apotex Health Corp and received $100 million in cash at closing
Company declared a special cash dividend of $1.50 per share payable around July 31, 2026 to shareholders of record as of July 23, 2026
2 more takeaways
Related Filings (3)
3 more filings from Cumberland Pharmaceuticals Inc. in the last 90 days
Filing Overview
What This Means
Cumberland Pharmaceuticals Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.